🔗 Share this article TikTok Influencers Driving Unofficial Market for Unlicensed Slimming Medication An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations. Investigational Drug Gaining Traction Online The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes. Thriving Commerce on Messaging Platforms Additionally, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for transactions. Understanding The Experimental Drug Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic. Healthcare Professionals Voice Concerns However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering products of unknown origin. Some professionals said the demand for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro. Regulatory Position and Implementation Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012. Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or prison. Service Response and Content Elimination According to TikTok, the platform has removed problematic material and banned associated keywords and search suggestions. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures. Online Marketplace Operations Research also discovered groups with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence. After moments of entering one community, a vendor posted WhatsApp details, where most purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, health issues or past usage. Item Information and Costs Inside these groups, posts display dark colored packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.” Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”. Platform Moderation and Safety Actions A representative for Telegram stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”. Medical Professional Warnings “People are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service. A medical professional of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said. Her team has already encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.” Manufacturer Position A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may subject users to possibly significant medical dangers”.